Analysis of the burden of prostate cancer in China in 1990 and 2017
Objective To analyze the trend of incidence, mortality and disease burden of prostate cancer in China between 1990 and 2017.Methods Based on the results of the Global Burden of Diseases 2017 (GBD 2017), Incidence, Mortality, Disability-Adjusted Life Years (DALY), Years of Life Lost (YLL), and Years...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2020-08-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/storage/attach/2008/dXbsVtm3j3eLSt2wdWBYnjK8e7N2uLyxEsJKDPfK.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850035591183335424 |
|---|---|
| author | Tong DENG Lin CAI Zheng CHEN Jia GUO Xing HUANG Chang-Xing KE Wen-Zhi LI Li JIANG Guan-Jun LU Xiao-Qiang LIU Jin-Hai FAN Xian-Tao ZENG |
| author_facet | Tong DENG Lin CAI Zheng CHEN Jia GUO Xing HUANG Chang-Xing KE Wen-Zhi LI Li JIANG Guan-Jun LU Xiao-Qiang LIU Jin-Hai FAN Xian-Tao ZENG |
| author_sort | Tong DENG |
| collection | DOAJ |
| description | Objective To analyze the trend of incidence, mortality and disease burden of prostate cancer in China between 1990 and 2017.Methods Based on the results of the Global Burden of Diseases 2017 (GBD 2017), Incidence, Mortality, Disability-Adjusted Life Years (DALY), Years of Life Lost (YLL), and Years Lived with Disability (YLD) of prostate cancer and its standardized rate were used to describe the burden of prostate cancer in China between 1990 and 2017.Results In 2017, the number of cases of prostate cancer in China was 144,900, the standardized incidence was 16.57 / 100 000, the number of deaths was 51,700, and the standardized mortality was 6.8 / 100 000. Compared with 1990, the number of cases increased by 432.72%, the standardized incidence increased by 98.21%, the number of deaths increased by 158.5%, and the standardized mortality decreased by 3.82%. Incidence and mortality are increasing with age. Compared with 1990, in 2017, the DALY standardization rate of prostate cancer in China decreased by 3.81%, the YLL standardization rate decreased by 9.73%, and the YLD standardization rate increased by 134.56%.Conclusions Compared with 1990, the overall disease burden of prostate cancer in China in 2017 showed a downward trend, but YLD showed an upward trend. The burden of prostate cancer disease in the elderly is still high and should be the focus of attention. |
| format | Article |
| id | doaj-art-e5e18fc715834ce991f8e75580ff8461 |
| institution | DOAJ |
| issn | 1004-5511 |
| language | zho |
| publishDate | 2020-08-01 |
| publisher | Editorial Office of New Medicine |
| record_format | Article |
| series | Yixue xinzhi zazhi |
| spelling | doaj-art-e5e18fc715834ce991f8e75580ff84612025-08-20T02:57:26ZzhoEditorial Office of New MedicineYixue xinzhi zazhi1004-55112020-08-0130425225910.12173/j.issn.1004-5511.2020.04.016162Analysis of the burden of prostate cancer in China in 1990 and 2017Tong DENGLin CAIZheng CHENJia GUOXing HUANGChang-Xing KEWen-Zhi LILi JIANGGuan-Jun LUXiao-Qiang LIUJin-Hai FANXian-Tao ZENGObjective To analyze the trend of incidence, mortality and disease burden of prostate cancer in China between 1990 and 2017.Methods Based on the results of the Global Burden of Diseases 2017 (GBD 2017), Incidence, Mortality, Disability-Adjusted Life Years (DALY), Years of Life Lost (YLL), and Years Lived with Disability (YLD) of prostate cancer and its standardized rate were used to describe the burden of prostate cancer in China between 1990 and 2017.Results In 2017, the number of cases of prostate cancer in China was 144,900, the standardized incidence was 16.57 / 100 000, the number of deaths was 51,700, and the standardized mortality was 6.8 / 100 000. Compared with 1990, the number of cases increased by 432.72%, the standardized incidence increased by 98.21%, the number of deaths increased by 158.5%, and the standardized mortality decreased by 3.82%. Incidence and mortality are increasing with age. Compared with 1990, in 2017, the DALY standardization rate of prostate cancer in China decreased by 3.81%, the YLL standardization rate decreased by 9.73%, and the YLD standardization rate increased by 134.56%.Conclusions Compared with 1990, the overall disease burden of prostate cancer in China in 2017 showed a downward trend, but YLD showed an upward trend. The burden of prostate cancer disease in the elderly is still high and should be the focus of attention.https://yxxz.whuznhmedj.com/storage/attach/2008/dXbsVtm3j3eLSt2wdWBYnjK8e7N2uLyxEsJKDPfK.pdfprostate cancer incidence mortality burden of disease disability-adjusted life years |
| spellingShingle | Tong DENG Lin CAI Zheng CHEN Jia GUO Xing HUANG Chang-Xing KE Wen-Zhi LI Li JIANG Guan-Jun LU Xiao-Qiang LIU Jin-Hai FAN Xian-Tao ZENG Analysis of the burden of prostate cancer in China in 1990 and 2017 Yixue xinzhi zazhi prostate cancer incidence mortality burden of disease disability-adjusted life years |
| title | Analysis of the burden of prostate cancer in China in 1990 and 2017 |
| title_full | Analysis of the burden of prostate cancer in China in 1990 and 2017 |
| title_fullStr | Analysis of the burden of prostate cancer in China in 1990 and 2017 |
| title_full_unstemmed | Analysis of the burden of prostate cancer in China in 1990 and 2017 |
| title_short | Analysis of the burden of prostate cancer in China in 1990 and 2017 |
| title_sort | analysis of the burden of prostate cancer in china in 1990 and 2017 |
| topic | prostate cancer incidence mortality burden of disease disability-adjusted life years |
| url | https://yxxz.whuznhmedj.com/storage/attach/2008/dXbsVtm3j3eLSt2wdWBYnjK8e7N2uLyxEsJKDPfK.pdf |
| work_keys_str_mv | AT tongdeng analysisoftheburdenofprostatecancerinchinain1990and2017 AT lincai analysisoftheburdenofprostatecancerinchinain1990and2017 AT zhengchen analysisoftheburdenofprostatecancerinchinain1990and2017 AT jiaguo analysisoftheburdenofprostatecancerinchinain1990and2017 AT xinghuang analysisoftheburdenofprostatecancerinchinain1990and2017 AT changxingke analysisoftheburdenofprostatecancerinchinain1990and2017 AT wenzhili analysisoftheburdenofprostatecancerinchinain1990and2017 AT lijiang analysisoftheburdenofprostatecancerinchinain1990and2017 AT guanjunlu analysisoftheburdenofprostatecancerinchinain1990and2017 AT xiaoqiangliu analysisoftheburdenofprostatecancerinchinain1990and2017 AT jinhaifan analysisoftheburdenofprostatecancerinchinain1990and2017 AT xiantaozeng analysisoftheburdenofprostatecancerinchinain1990and2017 |